Pharmazeutische Dosierformen

Patent europeic · EP2384754 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2384754
Numer da la dumonda
EP11157003
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
24-08-2007
Publitgà
09-11-2011
Concedì
20-03-2013
Stritgà
23-02-2022
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/485 (2006.01)
A61K 9/22 (2006.01)
A61K 9/32 (2006.01)
Prioritad
US 840244 P 25.08.2006
Derivà da
EP10192627
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-03-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.03.2022

  2. 24-04-2013

    Represchentant inscrit

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 24.04.2013

  3. 20-03-2013

    Concedì

    Published in Swissreg on 20.03.2013

Partidas

Inventur

Mannion, Richard Owen

Furlong, PA 18925, US

Huang, Haiyong Hugh

Princeton, NJ 08540, US

McKenna, William Henry

Yonkers, NY 10704, US

O'Donnell, Edward, P.

Basking Ridge, NJ 07920, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.